메뉴 건너뛰기




Volumn 61, Issue 2, 2001, Pages 759-763

Pretreatment with paclitaxel enhances Apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; CYTOCHROME C; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DOCETAXEL; FAS LIGAND; PACLITAXEL; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

EID: 0035863523     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (200)

References (25)
  • 9
    • 0032544268 scopus 로고    scopus 로고
    • Apoptotic pathways: The roads to ruin
    • (1998) Cell , vol.94 , pp. 695-698
    • Green, D.1
  • 15
    • 0030615086 scopus 로고    scopus 로고
    • Loverexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human AML HL-60 cells
    • (1997) Cancer Res. , vol.57 , pp. 1109-1115
    • Ibrado, A.M.1    Liu, L.2    Bhalla, K.3
  • 21
    • 0033572413 scopus 로고    scopus 로고
    • Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11
    • (1999) Cancer Res. , vol.59 , pp. 6153-6158
    • Gliniak, B.1    Le, T.2
  • 23
    • 0031028190 scopus 로고    scopus 로고
    • Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. III. Oncogenes, suppressor genes, and applications
    • (1997) Prostate , vol.30 , pp. 136-142
    • Webber, M.1    Bello, D.2    Quader, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.